Form 4: Director Wendy L Yarno Reports Stock Transactions in Tarsus Pharmaceuticals

Wendy L Yarno, a director of Tarsus Pharmaceuticals, reports the acquisition and disposal of common stock related to the settlement of restricted stock units.

Summary

• On June 24, 2024, Wendy L Yarno, a director of Tarsus Pharmaceuticals, engaged in transactions involving the company's common stock.
• Yarno acquired 3,350 shares of common stock through the settlement of vested Restricted Stock Units (RSUs).
• Concurrently, Yarno disposed of 3,350 shares.
• Following these transactions, Yarno beneficially owns 10,350 shares of Tarsus Pharmaceuticals common stock.
• The RSUs were granted on June 22, 2023, and vested on the one-year anniversary, contingent upon continuous service as a non-employee director.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock transactions by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their holdings in the company.

Stakeholder Impact

• The filing provides transparency to shareholders regarding the stock transactions of a company director.

Key Dates